Eton Pharmaceuticals (ETON) Non Operating Income: 2019-2024
Historic Non Operating Income for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to -$1.1 million.
- Eton Pharmaceuticals' Non Operating Income fell 7025.00% to -$1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.2 million, marking a year-over-year decrease of 340.76%. This contributed to the annual value of -$1.2 million for FY2024, which is 340.76% down from last year.
- Per Eton Pharmaceuticals' latest filing, its Non Operating Income stood at -$1.1 million for Q4 2024, which was down 14,150.00% from -$8,000 recorded in Q3 2024.
- Over the past 5 years, Eton Pharmaceuticals' Non Operating Income peaked at $676,000 during Q2 2023, and registered a low of -$1.1 million during Q4 2024.
- For the 3-year period, Eton Pharmaceuticals' Non Operating Income averaged around -$122,417, with its median value being -$89,000 (2023).
- As far as peak fluctuations go, Eton Pharmaceuticals' Non Operating Income surged by 410.09% in 2023, and later plummeted by 7,025.00% in 2024.
- Over the past 5 years, Eton Pharmaceuticals' Non Operating Income (Quarterly) stood at -$267,000 in 2020, then fell by 3.00% to -$275,000 in 2021, then skyrocketed by 45.45% to -$150,000 in 2022, then soared by 89.33% to -$16,000 in 2023, then crashed by 7,025.00% to -$1.1 million in 2024.
- Its last three reported values are -$1.1 million in Q4 2024, -$8,000 for Q3 2024, and -$52,000 during Q2 2024.